NasdaqGM - Nasdaq Real Time Price USD

United-Guardian, Inc. (UG)

9.30 +0.15 (+1.64%)
As of 12:31 PM EDT. Market Open.
Loading Chart for UG
DELL
  • Previous Close 9.15
  • Open 8.92
  • Bid --
  • Ask --
  • Day's Range 8.92 - 9.43
  • 52 Week Range 5.79 - 9.54
  • Volume 5,258
  • Avg. Volume 8,056
  • Market Cap (intraday) 42.729M
  • Beta (5Y Monthly) 0.68
  • PE Ratio (TTM) 16.61
  • EPS (TTM) 0.56
  • Earnings Date Aug 9, 2024 - Aug 13, 2024
  • Forward Dividend & Yield 0.35 (4.14%)
  • Ex-Dividend Date Feb 9, 2024
  • 1y Target Est --

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

www.u-g.com

23

Full Time Employees

December 31

Fiscal Year Ends

Recent News: UG

Performance Overview: UG

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

UG
32.91%
S&P 500
11.01%

1-Year Return

UG
3.23%
S&P 500
28.83%

3-Year Return

UG
29.68%
S&P 500
26.86%

5-Year Return

UG
39.60%
S&P 500
84.08%

Compare To: UG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UG

Valuation Measures

Annual
As of 5/16/2024
  • Market Cap

    43.05M

  • Enterprise Value

    34.44M

  • Trailing P/E

    15.62

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.72

  • Price/Book (mrq)

    3.86

  • Enterprise Value/Revenue

    2.98

  • Enterprise Value/EBITDA

    10.89

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    23.71%

  • Return on Assets (ttm)

    15.19%

  • Return on Equity (ttm)

    25.00%

  • Revenue (ttm)

    10.89M

  • Net Income Avi to Common (ttm)

    2.58M

  • Diluted EPS (ttm)

    0.56

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.09M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    2.22M

Research Analysis: UG

Company Insights: UG

Research Reports: UG

People Also Watch